Cart
0

ENT and Bronchoscopy Devices Market by Product (Endoscopes, Surgical ENT & Bronchoscopy Devices, and Hearing Care Devices) and End User (Hospitals & Clinics, Home Use, and Ambulatory Surgical Centers (ASCs)) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Get 20% Free Customization In This Report
LI_171878
Pages: 259
Mar 2017 | 2509 Views
 
Author's : Amrita Srivastava, Deepa Tatkare
Tables: 50
Charts: 99
 

ENT & Bronchoscopy Devices Overview:

Global ENT & bronchoscopy devices market was valued at $14,476 million in 2015, and is expected to reach $24,999 million by 2022, growing at a CAGR of 8.1% during the forecast period. ENT devices are used to rectify smelling disorders, hearing disorders as well as problems associated with speaking or snoring. Bronchoscopy involves examination of the complete airway of a patient including lungs and alveoli. Both ENT & bronchoscopy devices assist otolaryngologists to treat patients suffering from disorders of ear, nose, throat and related structures of the head and neck.

ENT and Bronchoscopy Devices Market

Get more information on this report : Request Sample Pages

The market is driven by factors such as rise in incidence of hearing and nasal disorders, new technological advancements in ENT & bronchoscopy devices, growth in geriatric population, and increase in patient preference for minimally invasive procedures. However, the market growth is limited by high cost of these devices (especially in developing nations) and dearth of skilled professionals. Conversely, the demand for cosmetic ENT procedures and the emerging markets of the Asia-Pacific and LAMEA regions are expected to provide several opportunities for market growth during the forecast period.

ENT and Bronchoscopy Devices Market

Get more information on this report : Request Sample Pages

ENT and Bronchoscopy Devices Market

Get more information on this report : Request Sample Pages

Segment Review

The hearing care devices segment accounted for the largest market share in 2015, due to increase in incidence of hearing disorders globally. According to the National Institute on Deafness and Other Communication Disorders (NIDCD), about 2 to 3 out of every 1,000 children in the U.S. are born with a detectable level of hearing loss in one or both ears. In addition, nearly 15% of adults (aged 18 years and above) in America have trouble in hearing. In addition, technological innovations in hearing devices have led to the development of miniature hearing aids that are not easily visible from outside, thus increasing the adoption of hearing aids. The development of anti-inflammatory drug-releasing cochlear implants is also expected to accelerate the market growth as the drug stops the immune reaction and inflammation in ear after surgery. Moreover, development of auditory brainstem implants is a major breakthrough for people with distorted auditory nerve. Hence, the hearing care market is expected to show considerable growth during the forecast period.

Snapshot of Brazilian ENT & bronchoscopy devices market

Rise in focus of market vendors on emerging markets, namely, Asia-Pacific and LAMEA regions, is expected to boost the market growth. According to the estimates of World Health Organization (WHO), nearly 14% (about 28 million people) of the Brazilian population suffers from some kind of hearing problem. In addition, estimates of The Brazilian Institute of Geography and Statistics (IBGE) also reported that approximately 5.2% (9.8 million people) of the Brazilian population suffers from hearing loss directly. Among these individuals, nearly 2.6 million are deaf and 7.2 million have difficulty in hearing. Furthermore, around 20% of Brazilian pre-school children are estimated to suffer from hearing loss. Approximately 15‐20% of the Brazilian population (nearly one-fifth) suffers from tinnitus (perception of noise or ringing in the ears). Thus, Brazil offers a huge customer base to the ENT & bronchoscopy device manufacturers.

Clinical Trials

ENT & bronchoscopy devices market has witnessed several clinical trials in the recent years. The hearing aids segment accounted for the maximum number of trials (247) in the market, owing to their increased demand due to increasing incidence of hearing disorders, affordability (low price as compared to hearing implants), and easy handling and usage. In addition, hearing aid manufacturers have adopted advanced technologies to improve the device efficiency and decrease its size. Therefore, new hearing aids are manufactured and hence need a successful clinical trial for marketing approval.  

The list of key players profiled in this report include Karl Storz Gmbh & Co. Kg, Medtronic PLC, Smith & Nephew PLC, Olympus Corporation, Johnson & Johnson (Acclarent, Inc.), Cochlear Limited, Hoya Corporation (Pentax medical), Sonova Holding AG, William Demant Holding A/S, Entellus Medical, Inc., MED-EL, Sivantos Pte. Ltd. and GN Store Nord A/S.

Key players in the value chain include IntriCon Corporation, Starkey Hearing Technologies, Oticon Medical, HayMed Instruments, and OPTOMIC ESPANA S.A.  

Ent and Bronchoscopy Devices Market Key Benefits:

  • The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis by product helps in understanding the various types of devices used for treatment and monitoring of patients suffering from ENT disorders.
  • Comprehensive analysis of all geographical regions is provided, which helps in determining the prevailing opportunities.
  • Key players are profiled and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the global market.

Ent and Bronchoscopy Devices Market Key Segments:

By Product

  • Endoscopes
    • Rigid Endoscopes
      • Otoscopes
      • Sinuscopes
    • Flexible Endoscopes
      • Laryngoscopes
      • Pharyngoscopes
      • Nasopharyngoscopes
      • Rhinoscopes
    • Hearing Screening Devices
    • Bronchoscopes
  • Surgical ENT & Bronchoscopy Devices
    • Powered Surgical Instruments
    • Radiofrequency Devices
    • Handheld Instruments
      • Rhinology Instruments
      • Otology Instruments
      • Laryngeal Instruments
      • Head & Neck Surgical Instruments
      • Other Handheld Instruments
    • Balloon sinus dilation devices
    • Nasal Stents
    • Bronchial/Tracheal Stents
    • Ear Tubes
    • ENT Lasers
    • Image-Guided Surgery Systems
  • Hearing Care Devices
    • Hearing Aids
      • Behind-the-Ear (BTE) Aids
      • In-the-Ear Aids
      • Receiver-in-the-Ear (RITE)
      • Canal Hearing Aids
    • Hearing Implants
      • Cochlear Implants
      • Bone-Anchored Hearing Systems (BAHS)
      • Auditory Brainstem Implants
      • Middle Ear Implants

By End User

  • Hospitals & Clinics
  • Home Use
  • Ambulatory Surgical Centers (ASCs)

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. MARKET SHARE ANALYSIS, 2015
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Growing incidence of hearing and nasal disorders
3.4.1.2. Technological advancements
3.4.1.3. Growing geriatric population
3.4.1.4. Increase in patient preference for minimally invasive procedures

3.4.2. Restraints

3.4.2.1. High cost of devices
3.4.2.2. Dearth of skilled professionals

3.4.3. Opportunities

3.4.3.1. Lucrative opportunities in the emerging economies
3.4.3.2. High demand for cosmetic ENT procedures

3.4.4. Impact analysis

3.5. CLINICAL TRIALS

Chapter: 4 ENT & BRONCHOSCOPY DEVICES MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. ENDOSCOPES

4.2.1. Rigid endoscopes

4.2.1.1. Otoscopes
4.2.1.2. Sinuscopes

4.2.2. Flexible endoscopes

4.2.2.1. Laryngoscopes
4.2.2.2. Pharyngoscopes
4.2.2.3. Rhinoscopes
4.2.2.4. Nasopharyngoscopes

4.2.3. Hearing screening devices
4.2.4. Bronchoscopes
4.2.5. Key market trends
4.2.6. Key growth factors and opportunities
4.2.7. Market size and forecast

4.3. SURGICAL ENT & BRONCHOSCOPY DEVICES

4.3.1. Powered surgical instruments
4.3.2. Radiofrequency devices
4.3.3. Handheld instruments

4.3.3.1. Rhinology instruments
4.3.3.2. Otology instruments
4.3.3.3. Laryngeal instruments
4.3.3.4. Head and neck surgical instruments
4.3.3.5. Other handheld instruments

4.3.4. Balloon sinus dilation devices
4.3.5. Nasal splints & stents
4.3.6. Bronchial/tracheal stents
4.3.7. Ear tubes
4.3.8. ENT lasers
4.3.9. Image-guided surgery systems
4.3.10. Key market trends
4.3.11. Key growth factors and opportunities
4.3.12. Market size and forecast

4.4. HEARING CARE DEVICES

4.4.1. Hearing aids

4.4.1.1. Behind-the-ear (BTE) aids
4.4.1.2. In-the-ear aids
4.4.1.3. Receiver-in-the-ear (RITE)
4.4.1.4. Canal hearing aids

4.4.2. Hearing implants

4.4.2.1. Cochlear implants
4.4.2.2. Bone-anchored hearing systems (BAHS)
4.4.2.3. Auditory brainstem implants
4.4.2.4. Middle ear implants

4.4.3. Key market trends
4.4.4. Key growth factors and opportunities
4.4.5. Market size and forecast

Chapter: 5 ENT & BRONCHOSCOPY DEVICES MARKET, BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS & CLINICS

5.2.1. Market size and forecast

5.3. HOME-USE

5.3.1. Market size and forecast

5.4. AMBULATORY SURGICAL CENTERS (ASCS)

5.4.1. Market size and forecast

Chapter: 6 ENT & BRONCHOSCOPY DEVICES MARKET, BY REGION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S.
6.2.5. Canada
6.2.6. Mexico

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany
6.3.5. France
6.3.6. UK
6.3.7. Italy
6.3.8. Spain
6.3.9. Rest of Europe

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan
6.4.5. China
6.4.6. India
6.4.7. South Korea
6.4.8. Australia
6.4.9. Rest of Asia-Pacific

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil
6.5.5. South Africa
6.5.6. Saudi Arabia
6.5.7. Rest of LAMEA

Chapter: 7 COMPANY PROFILES

7.1. COCHLEAR LIMITED

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Business performance
7.1.4. Key strategic moves and developments

7.2. ENTELLUS MEDICAL, INC.

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Business performance
7.2.5. Key strategic moves and developments

7.3. GN STORE NORD A/S

7.3.1. Overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Business performance
7.3.5. Key strategic moves and developments

7.4. HOYA CORPORATION (PENTAX MEDICAL)

7.4.1. Company overview
7.4.2. Operating business segments
7.4.3. Business performance
7.4.4. Key strategic moves and developments

7.5. JOHNSON & JOHNSON

7.5.1. Company overview
7.5.2. Operating business segments
7.5.3. Business performance
7.5.4. Key strategic moves and developments

7.6. KARL STORZ GMBH & CO. KG

7.6.1. Company overview
7.6.2. Operating business segments
7.6.3. Business performance
7.6.4. Key strategic moves and developments

7.7. MED-EL

7.7.1. Overview
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. MEDTRONIC PLC

7.8.1. Company Overview
7.8.2. Operating business segments
7.8.3. Business performance
7.8.4. Key strategic moves & developments

7.9. OLYMPUS CORPORATION

7.9.1. Company overview
7.9.2. Operating business segments
7.9.3. Business performance
7.9.4. Key strategic moves and developments

7.10. SIVANTOS PTE. LTD.

7.10.1. Overview
7.10.2. Business performance
7.10.3. Key strategic moves and developments

7.11. SMITH & NEPHEW PLC.

7.11.1. Company overview
7.11.2. Operating business segments
7.11.3. Business performance
7.11.4. Key strategic moves and developments

7.12. SONOVA HOLDING AG

7.12.1. Company overview
7.12.2. Operating business segments
7.12.3. Business Performance
7.12.4. Key strategic moves and developments

7.13. WILLIAM DEMANT HOLDING A/S

7.13.1. Company overview
7.13.2. Operating business segments
7.13.3. Business performance
7.13.4. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL ENT & BRONCHOSCOPY DEVICES MARKET, BY TYPE ($MILLION),  2014-2022
TABLE 2. GLOBAL ENDOSCOPES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 3. GLOBAL RIGID ENDOSCOPES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 4. GLOBAL FLEXIBLE ENDOSCOPES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 5. GLOBAL ENDOSCOPES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 6. GLOBAL ENDOSCOPES MARKET, BY END USER ($MILLION), 2014-2022
TABLE 7. GLOBAL SURGICAL ENT & BRONCHOSCOPY DEVICES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 8. GLOBAL HANDHELD INSTRUMENTS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 9. GLOBAL SURGICAL ENT & BRONCHOSCOPY DEVICES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 10. GLOBAL SURGICAL ENT & BRONCHOSCOPY DEVICES MARKET, BY END USER ($MILLION), 2014-2022
TABLE 11. GLOBAL HEARING CARE DEVICES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 12. GLOBAL HEARING AIDS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 13. GLOBAL HEARING IMPLANTS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 14. GLOBAL HEARING CARE DEVICES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 15. GLOBAL HEARING CARE DEVICES MARKET, BY END USER ($MILLION),  2014-2022
TABLE 16. GLOBAL ENT & BRONCHOSCOPY DEVICES MARKET, BY END USER ($MILLION), 2014-2022
TABLE 17. ENT & BRONCHOSCOPY DEVICES MARKET FOR HOSPITALS & CLINICS, BY REGION ($MILLION), 2014-2022
TABLE 18. ENT & BRONCHOSCOPY DEVICES MARKET FOR HOME-USE, BY REGION ($MILLION), 2014-2022
TABLE 19. ENT & BRONCHOSCOPY DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION ($MILLION), 2014-2022
TABLE 20. GLOBAL ENT & BRONCHOSCOPY DEVICES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 21. NORTH AMERICA ENT & BRONCHOSCOPY DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 22. NORTH AMERICA ENT & BRONCHOSCOPY DEVICES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 23. NORTH AMERICA ENT & BRONCHOSCOPY DEVICES MARKET, BY END USER ($MILLION), 2014-2022
TABLE 24. EUROPE ENT & BRONCHOSCOPY DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 25. EUROPE ENT & BRONCHOSCOPY DEVICES MARKET, BY TYPE ($MILLION),  2014-2022
TABLE 26. EUROPE ENT & BRONCHOSCOPY DEVICES MARKET, BY END USER ($MILLION), 2014-2022
TABLE 27. ASIA-PACIFIC ENT & BRONCHOSCOPY DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 28. ASIA-PACIFIC ENT & BRONCHOSCOPY DEVICES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 29. ASIA-PACIFIC ENT & BRONCHOSCOPY DEVICES MARKET, BY END USER ($MILLION), 2014-2022
TABLE 30. LAMEA ENT & BRONCHOSCOPY DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 31. LAMEA ENT & BRONCHOSCOPY DEVICES MARKET, BY TYPE ($MILLION),  2014-2022
TABLE 32. LAMEA ENT & BRONCHOSCOPY DEVICES MARKET, BY END USER ($MILLION), 2014-2022
TABLE 33. COCHLEAR: COMPANY SNAPSHOT
TABLE 34. ENTELLUS: COMPANY SNAPSHOT
TABLE 35. ENTELLUS: OPERATING SEGMENTS
TABLE 36. GN: COMPANY SNAPSHOT
TABLE 37. GN STORE NORD: OPERATING SEGMENTS
TABLE 38. HOYA: COMPANY SNAPSHOT
TABLE 39. HOYA: OPERATING SEGMENTS
TABLE 40. J&J: COMPANY SNAPSHOT
TABLE 41. J&J: OPERATING SEGMENTS
TABLE 42. KARL STORZ: COMPANY SNAPSHOT
TABLE 43. KARL STORZ: OPERATING SEGMENTS
TABLE 44. MED-EL: COMPANY SNAPSHOT
TABLE 45. MEDTRONIC: COMPANY SNAPSHOT
TABLE 46. OLYMPUS: COMPANY SNAPSHOT
TABLE 47. OLYMPUS: OPERATING SEGMENTS
TABLE 48. SIVANTOS COMPANY SNAPSHOT
TABLE 49. SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 50. SONOVA: COMPANY SNAPSHOT
TABLE 51. SONOVA: OPERATING SEGMENTS
TABLE 52. DEMANT: COMPANY SNAPSHOT
TABLE 53. DEMANT: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. ENT & BRONCHOSCOPY DEVICES MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014–2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 8. MARKET SHARE ANALYSIS, HEARING CARE DEVICES MARKET, 2015
FIGURE 9. TOP PLAYER POSITIONING, ENT ENDOSCOPES MARKET, 2015
FIGURE 10. TOP PLAYER POSITIONING, SURGICAL ENT & BRONCHOSCOPY DEVICES MARKET, 2015
FIGURE 11. DISTRIBUTION OF DISABLING HEARING LOSS PATIENTS (%), 2012
FIGURE 12. SURGICAL FACE & HEAD ENT COSMETIC PROCEDURES (%), 2015
FIGURE 13. SURGICAL FACE & HEAD ENT COSMETIC PROCEDURES PERFORMED IN MAJOR COUNTRIES (%), 2015
FIGURE 14. IMPACT ANALYSIS: ENT & BRONCHOSCOPY DEVICES MARKET
FIGURE 15. CLINICAL TRIALS FOR ENT & BRONCHOSCOPY DEVICES (%)
FIGURE 16. GEOGRAPHICAL DISTRIBUTION OF CLINICAL TRIALS FOR ENT & BRONCHOSCOPY DEVICES (%)
FIGURE 17. GEOGRAPHICAL DISTRIBUTION OF CLINICAL TRIALS FOR HEARING IMPLANTS (%)
FIGURE 18. GEOGRAPHICAL DISTRIBUTION OF CLINICAL TRIALS FOR HEARING AIDS (%)
FIGURE 19. GEOGRAPHICAL DISTRIBUTION OF CLINICAL TRIALS FOR SURGICAL ENT DEVICES (%)
FIGURE 20. GEOGRAPHICAL DISTRIBUTION OF CLINICAL TRIALS FOR ENT ENDOSCOPES (%)
FIGURE 21. GLOBAL ENT & BRONCHOSCOPY DEVICES MARKET, BY TYPE ($MILLION),  2014-2022
FIGURE 22. GLOBAL ENDOSCOPES MARKET, BY TYPE ($MILLION)
FIGURE 23. GLOBAL RIGID ENDOSCOPES MARKET, BY TYPE ($MILLION)
FIGURE 24. GLOBAL FLEXIBLE ENDOSCOPES MARKET, BY TYPE ($MILLION)
FIGURE 25. GLOBAL ENDOSCOPES MARKET, BY REGION ($MILLION)
FIGURE 26. GLOBAL ENDOSCOPES MARKET, BY END USER ($MILLION)
FIGURE 27. GLOBAL SURGICAL ENT & BRONCHOSCOPY DEVICES MARKET, BY TYPE ($MILLION)
FIGURE 28. GLOBAL HANDHELD INSTRUMENTS MARKET, BY TYPE ($MILLION)
FIGURE 29. GLOBAL SURGICAL ENT & BRONCHOSCOPY DEVICES MARKET, BY REGION ($MILLION)
FIGURE 30. GLOBAL SURGICAL ENT & BRONCHOSCOPY DEVICES MARKET, BY END USER ($MILLION)
FIGURE 31. GLOBAL HEARING CARE DEVICES MARKET, BY TYPE ($MILLION)
FIGURE 32. GLOBAL HEARING AIDS MARKET, BY TYPE ($MILLION)
FIGURE 33. GLOBAL HEARING IMPLANTS MARKET, BY TYPE ($MILLION)
FIGURE 34. HEARING CARE DEVICES MARKET, BY REGION ($MILLION)
FIGURE 35. GLOBAL HEARING CARE DEVICES MARKET, BY END USER ($MILLION),  2014-2022
FIGURE 36. GLOBAL ENT & BRONCHOSCOPY DEVICES MARKET, BY END USER ($MILLION)
FIGURE 37. ENT & BRONCHOSCOPY DEVICES MARKET FOR HOSPITALS & CLINICS, BY REGION ($MILLION)
FIGURE 38. ENT & BRONCHOSCOPY DEVICES MARKET FOR HOME-USE, BY REGION ($MILLION)
FIGURE 39. ENT & BRONCHOSCOPY DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION ($MILLION)
FIGURE 40. ENT & BRONCHOSCOPY DEVICES MARKET, BY REGION ($MILLION)
FIGURE 41. NORTH AMERICA ENT & BRONCHOSCOPY DEVICES MARKET, BY COUNTRY ($MILLION)
FIGURE 42. NORTH AMERICA ENT & BRONCHOSCOPY DEVICES MARKET, BY TYPE ($MILLION)
FIGURE 43. NORTH AMERICA ENT & BRONCHOSCOPY DEVICES MARKET, BY END USER ($MILLION)
FIGURE 44. U.S. ENT & BRONCHOSCOPY DEVICES MARKET ($MILLION), 2014–2022
FIGURE 45. CANADA ENT & BRONCHOSCOPY DEVICES MARKET ($MILLION), 2014–2022
FIGURE 46. MEXICO ENT & BRONCHOSCOPY DEVICES MARKET ($MILLION), 2014–2022
FIGURE 47. EUROPE ENT & BRONCHOSCOPY DEVICES MARKET, BY COUNTRY ($MILLION)
FIGURE 48. EUROPE ENT & BRONCHOSCOPY DEVICES MARKET, BY TYPE ($MILLION)
FIGURE 49. EUROPE ENT & BRONCHOSCOPY DEVICES MARKET, BY END USER ($MILLION)
FIGURE 50. GERMANY ENT & BRONCHOSCOPY DEVICES MARKET ($MILLION), 2014–2022
FIGURE 51. FRANCE ENT & BRONCHOSCOPY DEVICES MARKET ($MILLION), 2014–2022
FIGURE 52. UK ENT & BRONCHOSCOPY DEVICES MARKET ($MILLION), 2014–2022
FIGURE 53. ITALY ENT & BRONCHOSCOPY DEVICES MARKET ($MILLION), 2014–2022
FIGURE 54. SPAIN ENT & BRONCHOSCOPY DEVICES MARKET ($MILLION), 2014–2022
FIGURE 55. REST OF EUROPE ENT & BRONCHOSCOPY DEVICES MARKET ($MILLION),  2014–2022
FIGURE 56. ASIA-PACIFIC ENT & BRONCHOSCOPY DEVICES MARKET, BY COUNTRY ($MILLION)
FIGURE 57. ASIA-PACIFIC ENT & BRONCHOSCOPY DEVICES MARKET, BY TYPE ($MILLION)
FIGURE 58. ASIA-PACIFIC ENT & BRONCHOSCOPY DEVICES MARKET, BY END USER ($MILLION)
FIGURE 59. JAPAN ENT & BRONCHOSCOPY DEVICES MARKET ($MILLION), 2014–2022
FIGURE 60. CHINA ENT & BRONCHOSCOPY DEVICES MARKET ($MILLION), 2014–2022
FIGURE 61. INDIA ENT & BRONCHOSCOPY DEVICES MARKET ($MILLION), 2014–2022
FIGURE 62. SOUTH KOREA ENT & BRONCHOSCOPY DEVICES MARKET ($MILLION),  2014–2022
FIGURE 63. AUSTRALIA ENT & BRONCHOSCOPY DEVICES MARKET ($MILLION), 2014–2022
FIGURE 64. REST OF ASIA-PACIFIC ENT & BRONCHOSCOPY DEVICES MARKET ($MILLION), 2014–2022
FIGURE 65. LAMEA ENT & BRONCHOSCOPY DEVICES MARKET, BY COUNTRY ($MILLION)
FIGURE 66. LAMEA ENT & BRONCHOSCOPY DEVICES MARKET, BY TYPE ($MILLION)
FIGURE 67. LAMEA ENT & BRONCHOSCOPY DEVICES MARKET, BY END USER ($MILLION)
FIGURE 68. BRAZIL ENT & BRONCHOSCOPY DEVICES MARKET ($MILLION), 2014–2022
FIGURE 69. SOUTH AFRICA ENT & BRONCHOSCOPY DEVICES MARKET ($MILLION),  2014–2022
FIGURE 70. SAUDI ARABIA ENT & BRONCHOSCOPY DEVICES MARKET ($MILLION),  2014–2022
FIGURE 71. REST OF LAMEA ENT & BRONCHOSCOPY DEVICES MARKET ($MILLION),  2014–2022
FIGURE 72. COCHLEAR: NET SALES, 2014–2016 ($MILLION)
FIGURE 73. COCHLEAR: NET SALES BY GEOGRAPHY, 2016 (%)
FIGURE 74. ENTELLUS: NET SALES, ($MILLION), 2014-2016
FIGURE 75. ENTELLUS: NET SALES, BY GEOGRAPHY 2016 (%)
FIGURE 76. GN STORE NORD: NET SALES, 2014–2016 ($MILLION)
FIGURE 77. GN STORE NORD: NET SALES BY SEGMENT, 2016 (%)
FIGURE 78. GN STORE NORD: NET SALES BY GEOGRAPHY, 2016 (%)
FIGURE 79. HOYA: REVENUE, 2014–2016 ($MILLION)
FIGURE 80. HOYA: REVENUE BY SEGMENT, 2016 (%)
FIGURE 81. HOYA: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 82. J&J: REVENUE, BY YEAR ($MILLION) (2014-2016)
FIGURE 83. J&J: REVENUE, BY SEGMENT, 2016 (%)
FIGURE 84. J&J: REVENUE, BY REGION, 2016 (%)
FIGURE 85. MEDTRONIC: NET REVENUE, ($MILLION) (2014-2016)
FIGURE 86. MEDTRONIC: REVENUE BY SEGMENT, 2016 (%)
FIGURE 87. MEDTRONIC: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 88. OLYMPUS: REVENUE, 2014–2016 ($MILLION)
FIGURE 89. OLYMPUS: REVENUE BY SEGMENT, 2016 (%)
FIGURE 90. OLYMPUS: REVENUE BY REGION, 2016 (%)
FIGURE 91. SMITH & NEPHEW: REVENUE, 2014–2016 ($MILLION)
FIGURE 92. SMITH & NEPHEW: REVENUE BY PRODUCT, 2016 (%)
FIGURE 93. SMITH & NEPHEW: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 94. SONOVA: NET SALES, 2014-2016 ($MILLION)
FIGURE 95. SONOVA: REVENUE BY SEGMENT, 2016 (%)
FIGURE 96. SONOVA: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 97. DEMANT: REVENUE, 2013-2015 ($MILLION)
FIGURE 98. DEMANT: NET SALES, BY SEGMENT, 2015 (%)
FIGURE 99. DEMANT: NET SALES, BY GEOGRAPHY, 2015 (%)

 

The adoption of ENT & bronchoscopy devices, such as hearing aids and hearing implants, is expected to increase in the near future, owing to high prevalence of ENT disorders coupled with rise in geriatric population. The ENT & bronchoscopy devices market has gained the interest of healthcare providers due to the benefits offered by these devices for diagnosis and treatment of ENT disorders. There have been significant technological advancements in ENT & bronchoscopy devices to provide advanced treatment options for disease management. Asia-Pacific and LAMEA regions are expected to offer lucrative opportunities to market players, as the markets in the developed nations are saturated with large number of ENT & bronchoscopy devices providers.

The global market is driven by growth in incidence of hearing and nasal disorders, new technological advancements in these devices, rise in geriatric population, and increase in patient preference for minimally invasive procedures. However, this growth is restricted by high cost of these devices (especially in developing nations) and dearth of skilled professionals. Conversely, demand for cosmetic ENT procedures and emerging markets of the Asia-Pacific and LAMEA regions are expected to provide several growth opportunities during the forecast period.

Currently, the hearing care devices segment dominated the global ENT & bronchoscopy devices market, followed by the endoscope segment. The emerging nations witnessed rapid increase in the shipments of these devices to improve their healthcare infrastructure. This is expected to offset challenging conditions in the mature markets such as North America and Europe as these markets are near maturity phase. North America is expected to dominate the global market during the forecast period, followed by Europe.

 

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
ENT and Bronchoscopy Devices Market- Global Opportunity Analysis and Industry Forecast, 2014-2022

  • Online Only
  • $4176
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4640
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5540
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6654
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $9280
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo